To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.
NCT04944953 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2022-05-24
Summary
To compare the safety and efficacy of "HG-102" with Botox® in the improvement of moderate to severe glabellar lines.
Conditions
- Glabellar Lines
Interventions
- DRUG
-
Botulinum Toxin Type A Injection [Botox]
Single administration, Day 0, 20 units
- DRUG
-
Botulinum toxin type A injection [HG-102]
Single administration, Day 0, 20 units
Sponsors & Collaborators
-
Hugel
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-11
- Primary Completion
- 2021-09-02
- Completion
- 2021-12-16
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line
NCT03908008 ·Status: COMPLETED ·Phase: PHASE3
-
Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines
NCT04631588 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.
NCT05380154 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®
NCT03796351 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines
NCT06218251 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea
NCT02043145 ·Status: COMPLETED
-
Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone
NCT01186835 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants
NCT06174688 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
NCT01791881 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
NCT04996810 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DWP450 for Treating Moderate to Severe Glabellar Lines
NCT06354127 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
NCT05248880 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
NCT02353871 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
NCT02493946 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT00694148 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
NCT03216408 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of BOTOX For The Treatment Of Glabellar Lines
NCT00408785 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial
NCT04274608 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
NCT06499688 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248867 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®
NCT01608672 ·Status: COMPLETED
-
Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines
NCT03806933 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
NCT01271452 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Evaluation and Real-world Evidence of NT201
NCT05222607 ·Status: TERMINATED